Cancer Immunology, Immunotherapy丨12-Apr-23
BAP1-related signature predicts benefits from immunotherapy over VEGFR/mTOR inhibitors in ccRCC: a retrospective analysis of JAVELIN Renal 101 and checkmate-009/010/025 trials
Volume 72, pages 2557–2572, (2023)
Learn More